UCHL1 may promote doxorubicin (DOX) resistance in breast cancer (BC) by upregulating free fatty acid synthesis, as evidenced by reduced expression of FFA synthase and restored DOX sensitivity following UCHL1 inhibition (67). The gene discussed is UCHL1; the disease is breast cancer.